A Study to Check How Often People Treated With Darvadstrocel for Crohn's Disease Are Diagnosed With Cancer
Withdrawn
A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Completed
2,207 enrolled 10 charts
DUET
Phase 2 Withdrawn
A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
Phase 4 Completed
1 enrolled 1 chart
Urine Metabolites in the Diagnosis of Disease
Recruiting
1,250 enrolled
QUANTUM
Enrolling by invitation
3,000 enrolled
EVOLVE-IBERIA
Completed
409 enrolled 55 charts
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Recruiting
20,000 enrolled
Systems Biology of Gastrointestinal and Related Diseases
Terminated
17 enrolled
Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
Phase 2 Completed
121 enrolled 22 charts
Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease
Phase 2 Terminated
29 enrolled 25 charts
Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients
Completed
157 enrolled
Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease
Phase 3 Completed
205 enrolled 39 charts
PILLAR II
Phase 1 Completed
147 enrolled 14 charts
Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease
Phase 3 Completed
439 enrolled 25 charts
Welcome2
Phase 3 Completed
233 enrolled 31 charts
Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets
Completed
1,731 enrolled
Comparison of Intracorporeal and Extracorporeal Anastomoses for Minimally Invasive Right Colectomy
Completed
1,000 enrolled
IDEA
Completed
106 enrolled 13 charts
A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
Phase 3 Completed
769 enrolled 13 charts
Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease
Phase 2 Terminated
59 enrolled 13 charts
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Unknown
200 enrolled
RETROPRESS
Completed
171 enrolled
Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas
Phase 3 Withdrawn
A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease
Phase 3 Withdrawn
MUSIC
Phase 3 Completed
89 enrolled 43 charts